SCHEMBL38700

SCHEMBL38700

CCCCCCCCOCC(O)COc1ccc(-c2nc(-c3ccc(C)cc3C)nc(-c3ccc(C)cc3C)n2)c(O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G4B P0C869 2/20 0.44
CNR2 P34972 3/20 0.38
USP2 O75604 1/20 0.37
NR5A1 Q13285 1/20 0.37
HTT P42858 2/20 0.36
PLK1 P53350 2/20 0.36
PTPN11 Q06124 2/20 0.36
LPAR5 Q9H1C0 1/20 0.36
SLC2A1 P11166 1/20 0.35
ALDH1A1 P00352 2/20 0.34
MAPT P10636 2/20 0.34
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
GAA P10253 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
LMNA P02545 1/20 0.34
ATM Q13315 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30497720 1.00 PLA2G4B (0.44) PLA2G4BCNR2USP2NR5A1HTT
SCHEMBL29354743 1.00 PLA2G4B (0.44) PLA2G4BCNR2USP2NR5A1HTT
SCHEMBL7524555 1.00 PLA2G4B (0.44) PLA2G4BCNR2USP2NR5A1HTT
SCHEMBL7704728 1.00 PLA2G4B (0.44) PLA2G4BCNR2USP2NR5A1HTT
SCHEMBL29332411 1.00 PLA2G4B (0.44) PLA2G4BCNR2USP2NR5A1HTT
SCHEMBL4625753 1.00 PLA2G4B (0.44) PLA2G4BCNR2USP2NR5A1HTT
SCHEMBL7925990 1.00 PLA2G4B (0.44) PLA2G4BCNR2USP2NR5A1HTT
SCHEMBL31370 1.00 PLA2G4B (0.44) PLA2G4BCNR2USP2NR5A1HTT
SCHEMBL18231906 1.00 PLA2G4B (0.44) PLA2G4BCNR2USP2NR5A1HTT
SCHEMBL29349905 1.00 PLA2G4B (0.44) PLA2G4BCNR2USP2NR5A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9543521-B2 Organic semiconductor device and process for its production BASF SE (DE) 2017-01-10 US claimed
US-20140306212-A1 ORGANIC SEMICONDUCTOR DEVICE AND PROCESS FOR ITS PRODUCTION BASF SE (DE) 2014-10-16 US claimed
EP-2780409-A1 ORGANIC SEMICONDUCTOR DEVICE AND MANUFACTURING METHOD THEREOF BASF SE (DE) 2014-09-24 EP claimed
US-8664173-B2 Premoistened cleaning disposable substrate for leather and method of preserving a leather surface by contacting said surface with said substrate BASF SE (DE) 2014-03-04 US claimed
US-20130306151-A1 ORGANIC PHOTOVOLTAIC DEVICE AND MANUFACTURING METHOD THEREOF BASF SE (DE) 2013-11-21 US claimed
EP-2663595-A1 ORGANIC PHOTOVOLTAIC DEVICE AND MANUFACTURING METHOD THEREOF BASF SE (DE) 2013-11-20 EP claimed
WO-2013072853-A1 ORGANIC SEMICONDUCTOR DEVICE AND MANUFACTURING METHOD THEREOF BASF SE (DE) 2013-05-23 WO claimed
WO-2012095796-A1 ORGANIC PHOTOVOLTAIC DEVICE AND MANUFACTURING METHOD THEREOF BASF SE (DE) 2012-07-19 WO claimed
EP-1310492-B1 Phenyl ether-substituted hydroxyphenyl triazine ultraviolet light absorbers CYTEC TECH CORP (US) 2012-01-11 EP claimed
US-20080171683-A1 Premoistened cleaning disposable substrate for leather and method of preserving a leather surface by contacting said surface with said substrate BASF SE (DE) 2008-07-17 US claimed
WO-2003057772-A2 UV STABILIZED THERMOPLASTIC OLEFINS CYTEC TECHNOLOGY CORP. (US) 2003-07-17 WO claimed
EP-1310492-A1 Phenyl ether-substituted hydroxyphenyl triazine ultraviolet light absorbers CYTEC TECHNOLOGY CORP. (US) 2003-05-14 EP claimed
US-20030088098-A1 Novel red-shifted triazine ultravioletlight absorbers CYTEC TECHNOLOGY CORP. 2003-05-08 US claimed
WO-2003035733-A1 PROCESS FOR IMPROVING THE SHELF LIFE OF A HINDERED PHENOL ANTIOXIDANT CYTEC TECHNOLOGY CORP. (US) 2003-05-01 WO claimed
US-20030073771-A1 Process for improving the shelf life of a hindered phenol antioxidant CYTEC TECHNOLOGY CORP. 2003-04-17 US claimed
EP-1298126-A1 Novel red-shifted triazine ultraviolet light absorbers CYTEC TECHNOLOGY CORP. (US) 2003-04-02 EP claimed
US-20020161075-A1 Polymeric articles containing hindered amine light stabilizers based on multi-functional carbonyl compounds CYTEC TECHNOLOGY CORP. 2002-10-31 US claimed
US-6384113-B1 POLYMER STABILIZER; LOW VOLATILITY; WEATHERABILITY; YELLOWING RESISTANCE CYTEC TECHNOLOGY CORP. 2002-05-07 US claimed
US-20020028937-A1 Benzocycle-substituted triazine and pyrimidine ultraviolet light absorbers CYTEC TECHNOLOGY CORP. 2002-03-07 US claimed
US-6187919-B1 ULTRAVIOLET ABSORBERS CIBA SPECIALTY CHEMICALS CORPORATION 2001-02-13 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030088098-A1 Novel red-shifted triazine ultravioletlight absorbers SUN2, RAD52, XPO5 PLA2G4B 4852/4885CNR2 2753/4885USP2 955/4885
US-20020028937-A1 Benzocycle-substituted triazine and pyrimidine ultraviolet light absorbers ERCC5, ERCC4, ERCC2 PLA2G4B 4762/4885CNR2 2106/4885USP2 2368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.